Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39187
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOmote, Kazunori-
dc.contributor.authorVERBRUGGE, Frederik-
dc.contributor.authorSorimachi, Hidemi-
dc.contributor.authorOmar, Massar-
dc.contributor.authorPopovic, Dejana-
dc.contributor.authorObokata, Masaru-
dc.contributor.authorReddy, Yogesh N. V.-
dc.contributor.authorBorlaug, Barry A. A.-
dc.date.accessioned2023-01-09T10:47:21Z-
dc.date.available2023-01-09T10:47:21Z-
dc.date.issued2022-
dc.date.submitted2023-01-05T12:44:25Z-
dc.identifier.citationEUROPEAN JOURNAL OF HEART FAILURE, 25 (2) , p. 185-196-
dc.identifier.issn1388-9842-
dc.identifier.urihttp://hdl.handle.net/1942/39187-
dc.description.abstractAims Little data are available regarding prognostic implications of invasive exercise testing in heart failure with preserved ejection fraction (HFpEF). The present study aimed to investigate whether rest and exercise central haemodynamic abnormalities are associated with adverse clinical outcomes in patients with dyspnea.Methods and results Patients with exertional dyspnoea and ejection fraction >= 50% (n = 764) underwent invasive exercise testing and follow-up for heart failure hospitalization or death. There were 117 patients with events over a median follow-up of 2.7 (interquartile range 0.5-4.6) years. Among patients with normal resting pulmonary artery wedge pressure (PAWP) (< 15 mmHg, n = 380 [50%]), increased exercise PAWP (>= 25 mmHg) was present in 187 (24% of cohort) and was associated with 2.4-fold higher risk of events compared to those with normal exercise PAWP (< 25 mmHg, n = 193 [25%]) (hazard ratio [HR] 2.44; 95% confidence interval [CI] 1.11-5.36; p = 0.03), while patients with elevated resting PAWP (>= 15 mmHg, n = 384 [50%]) displayed even higher risk compared to HFpEF with normal resting PAWP (HR 2.24; 95% CI 1.38-3.65; p = 0.001). Similar findings were observed for rest/exercise right atrial pressure, and rest/exercise pulmonary artery pressures. Higher peak oxygen consumption was associated with decreased risk of events, and this relationship was solely explained by exercise cardiac output. In a multivariable-adjusted Cox model, each 1 standard deviation (SD) increase in exercise PAWP was associated with a 41% greater hazard of events (HR 1.41; 95% CI 1.13-1.76; p = 0.002), while each 1 SD decrease in exercise cardiac output was associated with a 37% increased risk (HR 0.63; 95% CI 0.47-0.83; p = 0.001).Conclusions Haemodynamic abnormalities currently used for diagnosis of HFpEF are associated with increased risk for adverse events. Treatments that reduce central pressures while improving cardiac output reserve may offer greatest benefit to improve outcomes in HFpEF. [GRAPHICS]-
dc.description.sponsorshipBarry A. Borlaug is supported by R01 HL128526 and U01 HL160226 from the NHLBI and W81XWH2210245 from the United States Department of Defense. Hidemi Sorimachi is supported by a research fellowship from the Uehara Memorial Foundation, Japan. Kazunori Omote is supported by Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad and the JSPS Overseas Research Fellowships from the Japan Society for the Promotion of Science. Frederik H. Verbrugge is supported by a Fellowship of the Belgian American Educational Foundation (BAEF) and by the Special Research Fund (BOF) of Hasselt University (BOF19PD04). Conflict of interest: BAB receives research support from the National Institutes of Health (NIH) and the United States Department of Defense, as well as research grant funding from AstraZeneca, Axon, GlaxoSmithKline, Medtronic, Mesoblast, Novo Nordisk, and Tenax Therapeutics; has served as a consultant for Actelion, Amgen, Aria, Axon Therapies, BD, Boehringer Ingelheim, Cytokinetics, Edwards Lifesciences, Eli Lilly, Imbria, Janssen, Merck, Novo Nordisk, NGM, NXT, and VADovations, and is named inventor (US Patent no. 10,307,179) for the tools and approach for a minimally invasive pericardial modification procedure to treat heart failure. All other authors have nothing to disclose. The authors thank the staff of the Mayo Clinic Earl Wood Catheterization Laboratory and the patients who agreed to participate in research, allowing for this study to be completed.-
dc.language.isoen-
dc.publisherWILEY-
dc.rights2022 European Society of Cardiology-
dc.subject.otherInvasive haemodynamics-
dc.subject.otherExercise haemodynamics-
dc.subject.otherHeart failureHeart failure with preserved ejection fraction-
dc.subject.otherOutcome-
dc.titleCentral haemodynamic abnormalities and outcome in patients with unexplained dyspnoea-
dc.typeJournal Contribution-
dc.identifier.epage196-
dc.identifier.issue2-
dc.identifier.spage185-
dc.identifier.volume25-
local.format.pages12-
local.bibliographicCitation.jcatA1-
dc.description.notesBorlaug, BA (corresponding author), Mayo Clin & Mayo Fdn, Dept Cardiovasc Med, 200 1st St SW, Rochester, MN 55905 USA.-
dc.description.notesborlaug.barry@mayo.edu-
local.publisher.place111 RIVER ST, HOBOKEN 07030-5774, NJ USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1002/ejhf.2747-
dc.identifier.pmid36420788-
dc.identifier.isi000899249400001-
dc.contributor.orcidOmote, Kazunori/0000-0002-8132-7173-
dc.identifier.eissn1879-0844-
local.provider.typewosris-
local.description.affiliation[Omote, Kazunori; Verbrugge, Frederik H. H.; Sorimachi, Hidemi; Omar, Massar; Popovic, Dejana; Obokata, Masaru; Reddy, Yogesh N. V.; Borlaug, Barry A. A.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA.-
local.description.affiliation[Omote, Kazunori] Hokkaido Univ, Fac Med, Dept Cardiovasc Med, Sapporo, Japan.-
local.description.affiliation[Verbrugge, Frederik H. H.] Hokkaido Univ, Grad Sch Med, Sapporo, Japan.-
local.description.affiliation[Verbrugge, Frederik H. H.] Univ Hosp Brussels, Ctr Cardiovasc Dis, Jette, Belgium.-
local.description.affiliation[Verbrugge, Frederik H. H.] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, Hasselt, Belgium.-
local.description.affiliation[Borlaug, Barry A. A.] Mayo Clin & Mayo Fdn, Dept Cardiovasc Med, 200 1st St SW, Rochester, MN 55905 USA.-
local.uhasselt.internationalyes-
item.contributorOmote, Kazunori-
item.contributorVERBRUGGE, Frederik-
item.contributorSorimachi, Hidemi-
item.contributorOmar, Massar-
item.contributorPopovic, Dejana-
item.contributorObokata, Masaru-
item.contributorReddy, Yogesh N. V.-
item.contributorBorlaug, Barry A. A.-
item.fulltextWith Fulltext-
item.fullcitationOmote, Kazunori; VERBRUGGE, Frederik; Sorimachi, Hidemi; Omar, Massar; Popovic, Dejana; Obokata, Masaru; Reddy, Yogesh N. V. & Borlaug, Barry A. A. (2022) Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea. In: EUROPEAN JOURNAL OF HEART FAILURE, 25 (2) , p. 185-196.-
item.accessRightsRestricted Access-
crisitem.journal.issn1388-9842-
crisitem.journal.eissn1879-0844-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Central haemodynamic abnormalities and outcome in patients with unexplained dyspnoea.pdf
  Restricted Access
Published version1.33 MBAdobe PDFView/Open    Request a copy
Show simple item record

WEB OF SCIENCETM
Citations

21
checked on Apr 30, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.